Acentus Paves Path to Innovation with Acquisition by Henry Schein
Deal News | Dec 04, 2024 | TT Capital Partners LLC
The healthcare sector is experiencing transformative M&A activity as companies pursue innovation and expansion in the rapidly evolving market. Highlights from the latest transactions include Henry Schein's acquisition of medical supplier Acentus and Boston Scientific's agreement to purchase medical device firm Intera Oncology. In venture capital news, Aizen Therapeutics secured $13 million for AI-powered drug discovery, while Avenzo Therapeutics and Enveda raised $386 million and $130 million, respectively, in their financing rounds. Other significant deals include Poseida Therapeutics entering into a merger agreement with Roche, valued at approximately $1.5 billion, and the continued market influence of private equity firms like Clearlake Capital and Arlington Capital. Additionally, healthcare technology and staffing providers such as CareMax and Republic Health Resources are adjusting strategies through divestitures and asset sales to optimize their operations. These transactions underscore key trends and strategic maneuvers shaping the future of healthcare.
Sectors
- Healthcare
- Private Equity
- Biotechnology
Geography
- United States – The majority of the transactions and companies involved are based in the United States, including acquisitions and investments involving U.S.-headquartered healthcare and biotech firms.
- Netherlands – Fortimedix Surgical, a Netherlands-based medical device company, was acquired by Medtronic, indicating international healthcare industry involvement.
Industry
- Healthcare – The article focuses on the healthcare industry, particularly concerning mergers, acquisitions, and investments that are driving transformation and innovation within healthcare services and technology.
- Private Equity – The activities of private equity firms are highlighted through various transactions and investments, showcasing their role in financing and driving changes within the healthcare sector.
- Biotechnology – The article discusses investments and acquisitions involving biotechnology companies, emphasizing their role in developing innovative therapies and technologies.
Financials
- $13M – Venture capital funding raised by Aizen Therapeutics for its AI-powered drug discovery platform.
- $386M – Total funds raised by Avenzo Therapeutics in a Series A / A-1 financing round for oncology therapies.
- $1.5 billion – Total equity value of Poseida Therapeutics' acquisition by Roche, including contingent value rights.
- $265M – Amount Community Health Systems is selling certain assets to AdventHealth.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| TripleTree | Source | Company | TripleTree is a healthcare investment bank providing insights on the M&A activities highlighted in the report. |
| Henry Schein | Acquirer | Company | Henry Schein is a distributor of medical and dental supplies that acquired Acentus. |
| Acentus | Target Company | Company | A Florida-based medical supplier specializing in Continuous Glucose Monitors. |
| Poseida Therapeutics | Target Company | Company | A clinical-stage cell therapy company entering into a merger agreement with Roche. |
| Roche Holdings, Inc. | Acquirer | Company | A multinational healthcare company acquiring Poseida Therapeutics. |
| Clearlake Capital Group | Selling Company | Private Equity | A private equity firm that sold TEAM Technologies to Arlington Capital Partners. |
| Arlington Capital Partners | Acquirer | Private Equity | A private equity firm involved in the acquisition of TEAM Technologies. |